MedKoo Cat#: 564107 | Name: TR100
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

TR100 is a first-in-class compound anti-tropomyosin (ATM), targeting tropomyosin isoform, Tpm3.1.

Chemical Structure

TR100
TR100
CAS#1128165-86-5

Theoretical Analysis

MedKoo Cat#: 564107

Name: TR100

CAS#: 1128165-86-5

Chemical Formula: C26H38N4O

Exact Mass: 422.3046

Molecular Weight: 422.62

Elemental Analysis: C, 73.89; H, 9.06; N, 13.26; O, 3.79

Price and Availability

Size Price Availability Quantity
5mg USD 295.00
25mg USD 740.00
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
TR-100; TR 100; TR100
IUPAC/Chemical Name
(E)-2-Cyano-3-[1-(3-dimethylamino-propyl)-2-methyl-1H-indol-3-yl]-N-octyl-acrylamide
InChi Key
XXRLIGWROLDOLS-ZBJSNUHESA-N
InChi Code
InChI=1S/C26H38N4O/c1-5-6-7-8-9-12-16-28-26(31)22(20-27)19-24-21(2)30(18-13-17-29(3)4)25-15-11-10-14-23(24)25/h10-11,14-15,19H,5-9,12-13,16-18H2,1-4H3,(H,28,31)/b22-19+
SMILES Code
O=C(NCCCCCCCC)/C(C#N)=C/C1=C(C)N(CCCN(C)C)C2=C1C=CC=C2
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 422.62 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Abouelezz HM, El-Kashef DH, Abdеlaziz RR, Nader MA. Tiron enhances the anti- cancer activity of doxorubicin in DMBA-induced breast cancer: Role of Notch signaling/apoptosis/autophagy/oxidative stress. Food Chem Toxicol. 2024 Nov;193:114968. doi: 10.1016/j.fct.2024.114968. Epub 2024 Aug 28. PMID: 39214269. 2: Cardona GI, Escobar MC, Acosta-González A, Marín P, Marqués S. Highly mercury-resistant strains from different Colombian Amazon ecosystems affected by artisanal gold mining activities. Appl Microbiol Biotechnol. 2022 Apr;106(7):2775-2793. doi: 10.1007/s00253-022-11860-y. Epub 2022 Mar 28. PMID: 35344092; PMCID: PMC8990959. 3: Regina C, Hamed E, Andrieux G, Angenendt S, Schneider M, Ku M, Follo M, Wachtel M, Ke E, Kikuchi K, Henssen AG, Schäfer BW, Boerries M, Wagers AJ, Keller C, Hettmer S. Negative correlation of single-cell PAX3:FOXO1 expression with tumorigenicity in rhabdomyosarcoma. Life Sci Alliance. 2021 Jun 29;4(9):e202001002. doi: 10.26508/lsa.202001002. PMID: 34187933; PMCID: PMC8321661. 4: Parreno J, Amadeo MB, Kwon EH, Fowler VM. Tropomyosin 3.1 Association With Actin Stress Fibers is Required for Lens Epithelial to Mesenchymal Transition. Invest Ophthalmol Vis Sci. 2020 Jun 3;61(6):2. doi: 10.1167/iovs.61.6.2. PMID: 32492110; PMCID: PMC7415280. 5: Sady S, Matuszak L, Błaszczyk A. Optimisation of ultrasonic-assisted extraction of bioactive compounds from chokeberry pomace using response surface methodology. Acta Sci Pol Technol Aliment. 2019 Jul-Sep;18(3):249-256. doi: 10.17306/J.AFS.0673. PMID: 31569907. 6: Kee AJ, Chagan J, Chan JY, Bryce NS, Lucas CA, Zeng J, Hook J, Treutlein H, Laybutt DR, Stehn JR, Gunning PW, Hardeman EC. On-target action of anti- tropomyosin drugs regulates glucose metabolism. Sci Rep. 2018 Mar 15;8(1):4604. doi: 10.1038/s41598-018-22946-x. PMID: 29545590; PMCID: PMC5854615. 7: Currier MA, Stehn JR, Swain A, Chen D, Hook J, Eiffe E, Heaton A, Brown D, Nartker BA, Eaves DW, Kloss N, Treutlein H, Zeng J, Alieva IB, Dugina VB, Hardeman EC, Gunning PW, Cripe TP. Identification of Cancer-Targeted Tropomyosin Inhibitors and Their Synergy with Microtubule Drugs. Mol Cancer Ther. 2017 Aug;16(8):1555-1565. doi: 10.1158/1535-7163.MCT-16-0873. Epub 2017 May 18. PMID: 28522589. 8: Bonello TT, Janco M, Hook J, Byun A, Appaduray M, Dedova I, Hitchcock- DeGregori S, Hardeman EC, Stehn JR, Böcking T, Gunning PW. A small molecule inhibitor of tropomyosin dissociates actin binding from tropomyosin-directed regulation of actin dynamics. Sci Rep. 2016 Jan 25;6:19816. doi: 10.1038/srep19816. PMID: 26804624; PMCID: PMC4726228. 9: Stehn JR, Haass NK, Bonello T, Desouza M, Kottyan G, Treutlein H, Zeng J, Nascimento PR, Sequeira VB, Butler TL, Allanson M, Fath T, Hill TA, McCluskey A, Schevzov G, Palmer SJ, Hardeman EC, Winlaw D, Reeve VE, Dixon I, Weninger W, Cripe TP, Gunning PW. A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells. Cancer Res. 2013 Aug 15;73(16):5169-82. doi: 10.1158/0008-5472.CAN-12-4501. Erratum in: Cancer Res. 2013 Oct 1;73(19):6094. PMID: 23946473. 10: Cirit Ü, Bağiş H, Demir K, Agca C, Pabuccuoğlu S, Varişli Ö, Clifford- Rathert C, Agca Y. Comparison of cryoprotective effects of iodixanol, trehalose and cysteamine on ram semen. Anim Reprod Sci. 2013 Jun;139(1-4):38-44. doi: 10.1016/j.anireprosci.2013.03.010. Epub 2013 Mar 30. PMID: 23602486. 11: Watanabe M, Miyasaka H, Iwata N, Maeda S, Kishida S, Hayashi H. [A case of superficial siderosis of the central nervous system with bilateral vestibular dysfunction]. No To Shinkei. 1997 Oct;49(10):931-5. Japanese. PMID: 9368892.